Annual CAPEX
$2.38 M
+$2.33 M+5423.26%
31 December 2023
Summary:
Cara Therapeutics annual capital expenditures is currently $2.38 million, with the most recent change of +$2.33 million (+5423.26%) on 31 December 2023. During the last 3 years, it has risen by +$2.03 million (+580.52%). CARA annual CAPEX is now at all-time high.CARA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$0.00
-$210.00 K-100.00%
30 September 2024
Summary:
Cara Therapeutics quarterly capital expenditures is currently $0.00, with the most recent change of -$210.00 thousand (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$323.00 thousand (-100.00%). CARA quarterly CAPEX is now -100.00% below its all-time high of $2.05 million, reached on 31 December 2023.CARA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$3.10 M
-$323.00 K-9.44%
30 September 2024
Summary:
Cara Therapeutics TTM capital expenditures is currently $3.10 million, with the most recent change of -$323.00 thousand (-9.44%) on 30 September 2024. Over the past year, it has increased by +$2.77 million (+859.13%). CARA TTM CAPEX is now -9.44% below its all-time high of $3.42 million, reached on 30 June 2024.CARA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5423.3% | -100.0% | +859.1% |
| 3 y3 years | +580.5% | - | - |
| 5 y5 years | +3153.4% | 0.0% | +7276.2% |
CARA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +5989.7% | -100.0% | -9.4% | +7104.6% | |
| 5 y | 5 years | at high | >+9999.0% | -100.0% | -9.4% | >+9999.0% | |
| alltime | all time | at high | >+9999.0% | -100.0% | -9.4% | >+9999.0% |
Cara Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $3.10 M(-9.4%) |
| June 2024 | - | $210.00 K(-74.9%) | $3.42 M(+6.5%) |
| Mar 2024 | - | $836.00 K(-59.3%) | $3.21 M(+35.2%) |
| Dec 2023 | $2.38 M(+5423.3%) | $2.05 M(+535.3%) | $2.38 M(+635.3%) |
| Sept 2023 | - | $323.00 K(>+9900.0%) | $323.00 K(+651.2%) |
| Dec 2022 | $43.00 K(+10.3%) | $0.00(0.0%) | $43.00 K(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $43.00 K(0.0%) |
| June 2022 | - | $0.00(-100.0%) | $43.00 K(0.0%) |
| Mar 2022 | - | $43.00 K(-74.3%) | $43.00 K(-87.7%) |
| Dec 2021 | $39.00 K(-88.8%) | - | - |
| Dec 2020 | $349.00 K(+1838.9%) | $167.00 K(-8.2%) | $349.00 K(+91.8%) |
| Sept 2020 | - | $182.00 K(>+9900.0%) | $182.00 K(+911.1%) |
| Dec 2019 | $18.00 K(-75.3%) | $0.00(0.0%) | $18.00 K(-57.1%) |
| Sept 2019 | - | $0.00(-100.0%) | $42.00 K(-40.0%) |
| June 2019 | - | $7000.00(-36.4%) | $70.00 K(-14.6%) |
| Mar 2019 | - | $11.00 K(-54.2%) | $82.00 K(+12.3%) |
| Dec 2018 | $73.00 K | $24.00 K(-14.3%) | $73.00 K(+49.0%) |
| Sept 2018 | - | $28.00 K(+47.4%) | $49.00 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $19.00 K(+850.0%) | $49.00 K(-5.8%) |
| Mar 2018 | - | $2000.00(>+9900.0%) | $52.00 K(-10.3%) |
| Dec 2017 | $58.00 K(-91.9%) | $0.00(-100.0%) | $58.00 K(-54.3%) |
| Sept 2017 | - | $28.00 K(+27.3%) | $127.00 K(-78.4%) |
| June 2017 | - | $22.00 K(+175.0%) | $589.00 K(-17.9%) |
| Mar 2017 | - | $8000.00(-88.4%) | $717.00 K(0.0%) |
| Dec 2016 | $717.00 K(+3485.0%) | $69.00 K(-85.9%) | $717.00 K(+9.5%) |
| Sept 2016 | - | $490.00 K(+226.7%) | $655.00 K(+294.6%) |
| June 2016 | - | $150.00 K(+1775.0%) | $166.00 K(+654.5%) |
| Mar 2016 | - | $8000.00(+14.3%) | $22.00 K(+10.0%) |
| Dec 2015 | $20.00 K(-52.4%) | $7000.00(+600.0%) | $20.00 K(-28.6%) |
| Sept 2015 | - | $1000.00(-83.3%) | $28.00 K(-41.7%) |
| June 2015 | - | $6000.00(0.0%) | $48.00 K(0.0%) |
| Mar 2015 | - | $6000.00(-60.0%) | $48.00 K(+14.3%) |
| Dec 2014 | $42.00 K(+740.0%) | $15.00 K(-28.6%) | $42.00 K(+50.0%) |
| Sept 2014 | - | $21.00 K(+250.0%) | $28.00 K(+154.5%) |
| June 2014 | - | $6000.00(+500.0%) | $11.00 K(+120.0%) |
| Dec 2013 | $5000.00 | $1000.00(-75.0%) | $5000.00(+25.0%) |
| Sept 2013 | - | $4000.00 | $4000.00 |
FAQ
- What is Cara Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Cara Therapeutics?
- What is Cara Therapeutics annual CAPEX year-on-year change?
- What is Cara Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Cara Therapeutics?
- What is Cara Therapeutics quarterly CAPEX year-on-year change?
- What is Cara Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Cara Therapeutics?
- What is Cara Therapeutics TTM CAPEX year-on-year change?
What is Cara Therapeutics annual capital expenditures?
The current annual CAPEX of CARA is $2.38 M
What is the all time high annual CAPEX for Cara Therapeutics?
Cara Therapeutics all-time high annual capital expenditures is $2.38 M
What is Cara Therapeutics annual CAPEX year-on-year change?
Over the past year, CARA annual capital expenditures has changed by +$2.33 M (+5423.26%)
What is Cara Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of CARA is $0.00
What is the all time high quarterly CAPEX for Cara Therapeutics?
Cara Therapeutics all-time high quarterly capital expenditures is $2.05 M
What is Cara Therapeutics quarterly CAPEX year-on-year change?
Over the past year, CARA quarterly capital expenditures has changed by -$323.00 K (-100.00%)
What is Cara Therapeutics TTM capital expenditures?
The current TTM CAPEX of CARA is $3.10 M
What is the all time high TTM CAPEX for Cara Therapeutics?
Cara Therapeutics all-time high TTM capital expenditures is $3.42 M
What is Cara Therapeutics TTM CAPEX year-on-year change?
Over the past year, CARA TTM capital expenditures has changed by +$2.77 M (+859.13%)